Journey Medical (DERM) Finished Goods (2020 - 2021)
Journey Medical (DERM) posted Finished Goods of $4.3 million for Q4 2021, down 30.37% on a QoQ basis from $6.2 million in Q3 2021, and up 205.56% year-over-year from $1.4 million in Q4 2020.
Journey Medical (DERM) Finished Goods (2020 - 2021) Analysis & Trends
Journey Medical's Finished Goods history runs 2 years deep, the most recent figure standing at $4.3 million for Q4 2021.
- Quarterly Finished Goods rose 205.56% year-over-year to $4.3 million in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $4.3 million (up 205.56% YoY) and the FY2021 annual result came in at $4.3 million, up 205.56% from the prior year.
- Finished Goods was $4.3 million for Q4 2021 at Journey Medical, down from $6.2 million in the prior quarter.
- Across five years, Finished Goods topped out at $6.2 million in Q3 2021 and bottomed at $1.4 million in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Journey Medical | 179.67 Mn | 152.45 Mn | 9.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 4.29 Mn |
| Sep 30, 2021 | 6.16 Mn |
| Dec 31, 2020 | 1.40 Mn |